BioSerenity, Inc.

Feb 16, 2021

WeHealth(TM) Digital Medicine and BioSerenity Initiate a New Phase to Accelerate Cardioskin(TM) Commercialization

Jan 05, 2021

BioSerenity Announces FDA Clearance for Electroencephalography (EEG) Wearable Device System

Jun 18, 2020

BioSerenity, Leader in Healthcare as a Service (HaaS), Helps Advance Understanding of COVID-19 Neurological Impact